Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Nebraska › Omaha
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Omaha, NE keessatti
Qorannoo 8 Luukemiya Limfoositiikii Keessummaa f Omaha fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Namoota walitti qabaa jiraSadarkaa 3
- Oncology Hematology West, Pc Dba Nebraska Cancer Specialists, Omaha
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- University of Nebraska Medical Center, Omaha
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Namoota walitti qabaa jiraSadarkaa 3
- University of Nebraska Medical Center, Omaha
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of Nebraska Medical Center, Omaha
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Namoota walitti qabaa jiraSadarkaa 4
- University Of Nebraska Medical Center, Omaha
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 4
- University Of Nebraska Medical Center, Omaha
Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti
- Boston, MAQorannoo 31
- Columbus, OHQorannoo 28
- Durham, NCQorannoo 27
- Washington, DCQorannoo 22
- Seattle, WAQorannoo 20
- Rochester, MNQorannoo 18
- New York City, NYQorannoo 18
- Houston, TXQorannoo 17
- Baldwin Park, CAQorannoo 16
- Milwaukee, WIQorannoo 15
- Chicago, ILQorannoo 14
- Cincinnati, OHQorannoo 14
Qorannoo biroo Omaha keessatti
- Kansarii ProstateQorannoo 27
- Kansara Qara'a Non-Small CellQorannoo 24
- Saree OljooQorannoo 22
- Saree (Gosoota Hunda)Qorannoo 18
- Kansarii ColorectalQorannoo 18
- Myeloma Baay’eeQorannoo 16
- Kansarii OvariiQorannoo 14
- Non-Hodgkin LymphomaQorannoo 14
- Kansarii PancreasQorannoo 14
- Kansara MetastatikiiQorannoo 13
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 13
- Cufama OnneeQorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.